Daxor (DXR) vs Microbot Medical (MBOT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed Microbot Medical (MBOT) over the past year, losing 20.0% versus a loss of 67.5%. Over five years, DXR leads with a -7.0% price change compared with -85.1% for MBOT. Microbot Medical is the larger company by market cap ($72.3 million vs $61.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | MBOT |
|---|---|---|
| Share price | $10.51 | $1.08 |
| Market cap | $61.36M | $72.32M |
| 1-day change | +0.48% | +0.64% |
| YTD return | -29.08% | -46.50% |
| 1-year return | -20.03% | -67.48% |
| 5-year return | -7.02% | -85.08% |
| P/E ratio (TTM) | 9.55 | — |
| EPS (TTM) | $1.10 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $3.17 |
| 52-week low | $8.56 | $1.05 |
| Distance from 52-week high | -28.79% | -66.03% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +90.29% | +487.85% |
| Average volume | 17.27K | 649.10K |
| Shares outstanding | 5.84M | 67.16M |
| Employees | — | 43 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed MBOT by 47.4 percentage points over the past year.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
DXR vs MBOT FAQ
Which is bigger, Daxor or Microbot Medical?
Microbot Medical (MBOT) is larger, with a market capitalization of $72.32M compared with $61.36M for Daxor (DXR).
Which stock has performed better over the past year, DXR or MBOT?
DXR returned -20.03% over the past 12 months, compared with -67.48% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and Microbot Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.